Related references
Note: Only part of the references are listed.First clinical comparison of Nobori –Biolimus A9 eluting stents with Cypher– Sirolimus eluting stents: Nobori Core nine months angiographic and one year clinical outcomes
Miodrag Ostojic et al.
EuroIntervention (2011)
Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients - An autopsy study
Gaku Nakazawa et al.
CIRCULATION (2008)
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease - A randomized trial
Gregg W. Stone et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Endothelial cell recovery between comparator polymer-based drug-eluting stents
Michael Joner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
Stephan Windecker et al.
LANCET (2008)
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
John A. Ormiston et al.
LANCET (2008)
Long-term clinical outcomes with sirolimus-eluting coronary stents - Five-year results of the RAVEL trial
Marie-Claude Morice et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation
Masaki Awata et al.
CIRCULATION (2007)
Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel Meeting on Patent Foramen Ovale Closure Devices
Tina L. Pinto Slottow et al.
CIRCULATION (2007)
Vascular responses to drug eluting stents - Importance of delayed healing
Aloke V. Finn et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation
Gregg W. Stone et al.
CIRCULATION (2007)
Pathological correlates of late drug-eluting stent thrombosis - Strut coverage as a marker of endothelialization
Aloke V. Finn et al.
CIRCULATION (2007)
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:: data from a large two-institutional cohort study
Joost Daemen et al.
LANCET (2007)
Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression - A potential prothrombotic mechanism of drug-eluting stents
James A. S. Muldowney et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography
Daisuke Matsumoto et al.
EUROPEAN HEART JOURNAL (2007)
Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease - A randomized controlled trial
David E. Kandzari et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
BioMatrix® Biolimus A9®-eluting coronary stent:: a next-generation drug-eluting stent for coronary artery disease
Eberhard Grube et al.
EXPERT REVIEW OF MEDICAL DEVICES (2006)
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine encapsulated stent for treatment of native coronary artery lesions:: Clinical and angiographic results of the ENDEAVOR II trial
Jean Fajadet et al.
CIRCULATION (2006)
Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation
Barbara E. Staehli et al.
CIRCULATION RESEARCH (2006)
Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk
Michael Joner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss
J Mehilli et al.
CIRCULATION (2006)
Hypersensitivity cases associated with drug-eluting coronary stents - A review of available cases from the research on adverse drug events and reports (RADAR) project
JR Nebeker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation
SH Hofma et al.
EUROPEAN HEART JOURNAL (2006)
Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients
J Aoki et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Rapamycin, but not FK-506, increases endothelial tissue factor expression -: Implications for drug-eluting stent design
J Steffel et al.
CIRCULATION (2005)
Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction
M Togni et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents
AV Finn et al.
CIRCULATION (2005)
Endothelial progenitor cell capture by stents coated with antibody against CD34 - The HEALING-FIM (healthy endothelial accelerated lining inhibits neointimal growth-first in man) registry
J Aoki et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating
R Wessely et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent should we be cautious?
R Virmani et al.
CIRCULATION (2004)
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease
GW Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
JW Moses et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Toxicity of methyl methacrylate in dentistry
PA Leggat et al.
INTERNATIONAL DENTAL JOURNAL (2003)
Occupational allergies caused by latex
DDF Ahmed et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2003)
Intracoronary stenting and angiographic results:: Strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial
J Pache et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Sirolimus-eluting stent implanted in human coronary artery for 16 months - Pathological findings
G Guagliumi et al.
CIRCULATION (2003)
Taxanes: Microtubule and Centrosome Targets, and Cell Cycle Dependent Mechanisms of Action
M. Abal et al.
CURRENT CANCER DRUG TARGETS (2003)
Inflammation and restenosis: implications for therapy
MMPC Donners et al.
ANNALS OF MEDICINE (2003)
Results of prevention of restenosis with tranilast and its outcomes (PRESTO) trial
DR Holmes et al.
CIRCULATION (2002)
Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxel
FD Kolodgie et al.
CIRCULATION (2002)
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
M Morice et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model
T Suzuki et al.
CIRCULATION (2001)
Pathological analysis of local delivery of paclitaxel via a polymer-coated stent
A Farb et al.
CIRCULATION (2001)
Synthetic biodegradable polymers as orthopedic devices
JC Middleton et al.
BIOMATERIALS (2000)
Share Paper
